Citigroup’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Sell |
315,662
-293,726
| -48% | -$10.8M | 0.01% | 941 |
|
|
2025
Q1 | $21.5M | Buy |
609,388
+340,934
| +127% | +$12.1M | 0.01% | 677 |
|
|
2024
Q4 | $11.7M | Buy |
268,454
+150,516
| +128% | +$6.58M | 0.01% | 878 |
|
|
2024
Q3 | $5.35M | Buy |
117,938
+59,571
| +102% | +$2.7M | ﹤0.01% | 1293 |
|
|
2024
Q2 | $2.27M | Sell |
58,367
-219,308
| -79% | -$8.51M | ﹤0.01% | 1672 |
|
|
2024
Q1 | $8.95M | Buy |
277,675
+116,634
| +72% | +$3.76M | 0.01% | 946 |
|
|
2023
Q4 | $4.62M | Buy |
161,041
+63,807
| +66% | +$1.83M | ﹤0.01% | 1169 |
|
|
2023
Q3 | $2.69M | Sell |
97,234
-25,290
| -21% | -$700K | ﹤0.01% | 1320 |
|
|
2023
Q2 | $3.28M | Sell |
122,524
-141,244
| -54% | -$3.78M | ﹤0.01% | 1349 |
|
|
2023
Q1 | $5.71M | Buy |
263,768
+156,876
| +147% | +$3.4M | ﹤0.01% | 1064 |
|
|
2022
Q4 | $2.55M | Sell |
106,892
-138,253
| -56% | -$3.29M | ﹤0.01% | 1365 |
|
|
2022
Q3 | $4.83M | Buy |
245,145
+135,598
| +124% | +$2.67M | ﹤0.01% | 1150 |
|
|
2022
Q2 | $2.14M | Buy |
109,547
+80,987
| +284% | +$1.58M | ﹤0.01% | 1533 |
|
|
2022
Q1 | $729K | Sell |
28,560
-107,298
| -79% | -$2.74M | ﹤0.01% | 2586 |
|
|
2021
Q4 | $3.42M | Buy |
135,858
+62,564
| +85% | +$1.57M | ﹤0.01% | 1556 |
|
|
2021
Q3 | $2.02M | Sell |
73,294
-49,023
| -40% | -$1.35M | ﹤0.01% | 1916 |
|
|
2021
Q2 | $3.88M | Buy |
122,317
+31,314
| +34% | +$994K | ﹤0.01% | 1627 |
|
|
2021
Q1 | $4.18M | Buy |
91,003
+80,526
| +769% | +$3.69M | ﹤0.01% | 1443 |
|
|
2020
Q4 | $415K | Buy |
10,477
+7,973
| +318% | +$316K | ﹤0.01% | 2753 |
|
|
2020
Q3 | $87K | Sell |
2,504
-1,648
| -40% | -$57.3K | ﹤0.01% | 3209 |
|
|
2020
Q2 | $131K | Buy |
4,152
+29
| +0.7% | +$915 | ﹤0.01% | 3299 |
|
|
2020
Q1 | $90K | Buy |
+4,123
| New | +$90K | ﹤0.01% | 3358 |
|